Literature DB >> 3275435

Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses.

A E Tollefson1, W S Wold.   

Abstract

Early region E3 of adenovirus type 5 should encode at least nine proteins as judged by the DNA sequence and the spliced structures of the known mRNAs. Only two E3 proteins have been proved to exist, a glycoprotein (gp19K) and an 11,600-molecular-weight protein (11.6K protein). Here we describe an abundant 14.7K protein coded by a gene in the extreme 3' portion of E3. To identify this 14.7K protein, we constructed a bacterial vector which synthesized a TrpE-14.7K fusion protein, then we prepared antiserum against the fusion protein. This antiserum immunoprecipitated the 14.7K protein from cells infected with adenovirus types 5 and 2, as well as with a variety of E3 deletion mutants. Synthesis of the 14.7K protein correlated precisely with the presence or absence of the 14.7K gene and with the synthesis of the mRNA (mRNA h) which encodes the 14.7K protein. The 14.7K protein appeared as a triplet on immunoprecipitation gels and Western blots (immunoblots).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275435      PMCID: PMC250498     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse.

Authors:  C Signäs; M G Katze; H Persson; L Philipson
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

2.  Apple II computer software for DNA and protein sequence data.

Authors:  R Larson; J Messing
Journal:  DNA       Date:  1983

3.  Complex formation of class I transplantation antigens and a viral glycoprotein.

Authors:  O Kämpe; D Bellgrau; U Hammerling; P Lind; S Pääbo; L Severinsson; P A Peterson
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

4.  Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

Authors:  S S Challberg; G Ketner
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

5.  A nonessential glycoprotein is coded by early region E3 of adenovirus type 7.

Authors:  Q S Kapoor; W S Wold; G Chinnadurai
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

6.  DNA sequence of the early E3 transcription unit of adenovirus 5.

Authors:  C Cladaras; W S Wold
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

7.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector.

Authors:  S Pääbo; F Weber; O Kämpe; W Schaffner; P A Peterson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

9.  Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2.

Authors:  W S Wold; C Cladaras; S C Magie; N Yacoub
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Mapping the 5' ends, 3' ends, and splice sites of mRNAs from the early E3 transcription unit of adenovirus 5.

Authors:  C Cladaras; B Bhat; W S Wold
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

View more
  25 in total

1.  Characterization of Ad5 E3-14.7K, an adenoviral inhibitor of apoptosis: structure, oligomeric state, and metal binding.

Authors:  Hee-Jung Kim; Mark P Foster
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

2.  Mutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cells.

Authors:  Ann E Tollefson; Abraham Scaria; Baoling Ying; William S M Wold
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus.

Authors:  H A Brady; A Scaria; W S Wold
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection.

Authors:  A E Tollefson; A Scaria; S K Saha; W S Wold
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.

Authors:  Drew L Lichtenstein; Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; William S M Wold; Ann E Tollefson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus.

Authors:  A E Tollefson; P Krajcsi; S P Yei; C R Carlin; W S Wold
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  The mouse adenovirus type 1 contains an unusual E3 region.

Authors:  K S Raviprakash; A Grunhaus; M A el Kholy; M S Horwitz
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.

Authors:  M D Lubeck; A R Davis; M Chengalvala; R J Natuk; J E Morin; K Molnar-Kimber; B B Mason; B M Bhat; S Mizutani; P P Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.

Authors:  Tom A Zanardi; Soonpin Yei; Drew L Lichtenstein; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.